ArticleActa pharmaceutica Sinica. B2022

Discovery of ARF1-targeting inhibitor demethylzeylasteral as a potential agent against breast cancer.

Jie Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.